MedPath

Tracheostomy in ICU With a Double Lumen Endotracheal Tube

Not Applicable
Conditions
Neurological Disease
Acute Respiratory Failure
Heart Failure
Interventions
Device: Double lumen endotracheal tube tracheostomy
Registration Number
NCT01691222
Lead Sponsor
University of Genova
Brief Summary

Percutaneous tracheostomy in Intensive care unit (ICU) is performed with the use of flexible fiberoptic bronchoscope inside the conventional single lumen endotracheal tube owned by the patients. This situation may lead to many disadvantages for ventilation and airway protection of critically ill patients during the procedures. The use of double lumen endotracheal tube dedicated to the percutaneous tracheostomies may:

1. improve the ventilation of patients during the procedure,

2. protect the posterior tracheal wall from damage related to the different step of tracheostomies,

3. protect the lungs from blood and secretions coming down from the chosen site of tracheostomy.

So the aim of this study is to evaluate the oxygenation, gas exchange, ventilation and complications of percutaneous tracheostomies performed in ICU with a dedicated double lumen endotracheal tube.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • age ≥ 18 years and at least one of following criteria:
  • prolonged endotracheal intubation
  • prolonged mechanical ventilation
  • difficult/prolonged weaning
  • inability to protect the airway
Read More
Exclusion Criteria
  • infection of neck tissues
  • previous surgical neck interventions
  • recent surgical interventions or fracture of the cervical spine
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Double lumen endotracheal tube tracheostomyDouble lumen endotracheal tube tracheostomyTracheostomy with a dedicated double lumen endotracheal tube
Primary Outcome Measures
NameTimeMethod
change in gas-exchangeat the baseline and the end of the procedure (average time expected for the procedure is 30 minutes)

The investigator will perform an arterial blood gas to evaluate PaO2/FiO2 ratio

Secondary Outcome Measures
NameTimeMethod
early complicationsin the first 24 hours from the end of the procedure

early complications are:multiple intubation attempts (more than 1), accidental extubation, paratracheal insertion, injuries to blood vessels in the neck, oesophageal injury, accidental decannulation, malposition of the tracheostomy tube, tracheal cuff puncture, multiple punctures (more than 1), surgical conversion and percutaneous tracheostomy failure, minor bleeding (compressible), major bleeding (incompressible), pneumothorax,

change in air-trappingat the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)

the investigator will record auto-PEEP at the of expiration as a measure of air-trapping

change in peak airway pressureat the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)

the investigator will record peak airway pressure

change in plateau airway pressureat the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)

the investigator will record plateau airway pressure

change in arterial carbon dioxideat the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes)

the investigator will perform an arterial blood gas to evaluate PaCO2

late complicationsfrom the 2nd day ofter the procedure until the ICU discharge (expected average of 2 weeks)

late complications are: minor bleeding (compressible), major bleeding (incompressible) tracheostomy puncture site infection, subglottic stenosis, fracture of a tracheal cartilage, granuloma.

Trial Locations

Locations (2)

University of Genoa

🇮🇹

Genoa, Italy

University of Naples "Federico II"

🇮🇹

Naples, Italy

© Copyright 2025. All Rights Reserved by MedPath